Pages that link to "Q43805317"
Jump to navigation
Jump to search
The following pages link to Quantitation of GSTP1 methylation in non-neoplastic prostatic tissue and organ-confined prostate adenocarcinoma. (Q43805317):
Displaying 50 items.
- KIF1A and EDNRB are differentially methylated in primary HNSCC and salivary rinses (Q24600000) (← links)
- DAPK1 Promoter Methylation and Cervical Cancer Risk: A Systematic Review and a Meta-Analysis (Q26798393) (← links)
- Epigenetic modulators as therapeutic targets in prostate cancer (Q28071912) (← links)
- The power and the promise of DNA methylation markers (Q28188233) (← links)
- Biomarkers in cancer staging, prognosis and treatment selection (Q28278305) (← links)
- Methylation of the CpG sites only on the sense strand of the APC gene is specific for hepatocellular carcinoma (Q28743228) (← links)
- Emerging molecular markers of cancer. (Q30330271) (← links)
- Identification of prostate cancer mRNA markers by averaged differential expression and their detection in biopsies, blood, and urine (Q30479606) (← links)
- Impact of hormonal therapy on the detection of promoter hypermethylation of the detoxifying glutathione-S-transferase P1 gene (GSTP1) in prostate cancer (Q33248081) (← links)
- Hypermethylation of RASSF1A in human and rhesus placentas (Q33275493) (← links)
- In silico mining identifies IGFBP3 as a novel target of methylation in prostate cancer. (Q33282538) (← links)
- Quantitative promoter methylation analysis of multiple cancer-related genes in renal cell tumors (Q33291459) (← links)
- DNA hypermethylation and clinicopathological features in breast cancer: the Western New York Exposures and Breast Cancer (WEB) Study (Q33332509) (← links)
- Genetic and epigenetic characteristics of human multiple hepatocellular carcinoma (Q33711037) (← links)
- Phenotype-specific CpG island methylation events in a murine model of prostate cancer (Q33775468) (← links)
- Epigenetic Signature: A New Player as Predictor of Clinically Significant Prostate Cancer (PCa) in Patients on Active Surveillance (AS) (Q33838513) (← links)
- A reciprocal role of prostate cancer on stromal DNA damage (Q34000472) (← links)
- Promoter Methylation in Prostate Cancer and its Application for the Early Detection of Prostate Cancer Using Serum and Urine Samples (Q34014559) (← links)
- Oxidative stress and DNA methylation in prostate cancer (Q34021985) (← links)
- DNA methylation of cancer genome. (Q34133706) (← links)
- Novel diagnostic biomarkers for prostate cancer (Q34231678) (← links)
- The expression and clinical significance of GTP-binding RAS-like 3 (ARHI) and microRNA 221 and 222 in prostate cancer (Q34236061) (← links)
- Human prostate cancer risk factors (Q34360616) (← links)
- Epigenetic changes in prostate cancer: implication for diagnosis and treatment (Q34385658) (← links)
- Identification of new differentially methylated genes that have potential functional consequences in prostate cancer (Q34465132) (← links)
- DNA alterations in body fluids as molecular tumor markers for urological malignancies (Q34696425) (← links)
- Genome-Wide Epigenetic Modifications in Cancer (Q34731480) (← links)
- Epigenetics in cancer: implications for early detection and prevention (Q35021339) (← links)
- Serum biomarkers for detection of head and neck squamous cell carcinoma. (Q35050148) (← links)
- Alcohol consumption in relation to aberrant DNA methylation in breast tumors (Q35109249) (← links)
- Sensitive Detection of DNA Methylation (Q35118487) (← links)
- Body mass and DNA promoter methylation in breast tumors in the Western New York Exposures and Breast Cancer Study (Q35163939) (← links)
- GSTP1 promoter methylation is associated with recurrence in early stage prostate cancer (Q35322421) (← links)
- Detection of promoter hypermethylation in salivary rinses as a biomarker for head and neck squamous cell carcinoma surveillance (Q35547513) (← links)
- Polycyclic aromatic hydrocarbon-DNA adduct formation in prostate carcinogenesis. (Q35567486) (← links)
- DNA methylation changes in prostate cancer: current developments and future clinical implementation (Q35636543) (← links)
- Changes in CpG islands promoter methylation patterns during ductal breast carcinoma progression (Q35636561) (← links)
- Establishment and validation of real-time polymerase chain reaction method for CDH1 promoter methylation (Q35747601) (← links)
- Detection of TIMP3 promoter hypermethylation in salivary rinse as an independent predictor of local recurrence-free survival in head and neck cancer (Q35784536) (← links)
- Precision and performance characteristics of bisulfite conversion and real-time PCR (MethyLight) for quantitative DNA methylation analysis (Q35790157) (← links)
- AIM1 promoter hypermethylation as a predictor of decreased risk of recurrence following radical prostatectomy (Q35989658) (← links)
- Recent advances in biomarkers for cancer diagnosis and treatment (Q36196830) (← links)
- Locked nucleic acids can enhance the analytical performance of quantitative methylation-specific polymerase chain reaction (Q36329305) (← links)
- Genetic and epigenetic biomarkers in cancer : improving diagnosis, risk assessment, and disease stratification (Q36463216) (← links)
- Methylation of tumour suppressor genes APAF-1 and DAPK-1 and in vitro effects of demethylating agents in bladder and kidney cancer (Q36612596) (← links)
- Coordinate hypermethylation at specific genes in prostate carcinoma precedes LINE-1 hypomethylation (Q36695645) (← links)
- Estrogens and aspects of prostate disease (Q36697811) (← links)
- DNA methylation of GSTP1 as biomarker in diagnosis of prostate cancer (Q36725624) (← links)
- Gene methylation and early detection of genitourinary cancer: the road ahead (Q36856466) (← links)
- High specificity of quantitative methylation-specific PCR analysis for MGMT promoter hypermethylation detection in gliomas (Q37208268) (← links)